NEW YORK--(BUSINESS WIRE)--Daxor Corporation (AMEX:DXR), a medical instrumentation and biotechnology company, today announced the receipt of a signed trial agreement from the University of Medicine and Dentistry of New Jersey (UMDNJ) of Newark, New Jersey.
